Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, ...

Profiling cells from ovarian endometriosis revealed signaling interactions that may sustain legion growth, highlighting ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...

Reproductive steroids are powerful hormones that play a key role in the growth and development of our bodies, especially during puberty.

Worldwide, 1 in 10 women of reproductive age suffer from a condition known as endometriosis. It’s an illness where tissue ...

With a significant rise in endometriosis cases among women aged 20-40, early intervention and awareness are crucial to reduce ...

Endometriosis affects 1 in 10 women, often leading to pain and infertility. Early intervention is crucial due to rising cases among women aged 20-40. Experts urge lifestyle changes and regular ...

The NHS is offering trans men a fertility treatment that many women are denied due to its cost - forcing them to go private, it has been revealed. Biological females who want to transition are able to ...